Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
5'-Deoxy-5-fluorouridineプロドラッグ含有リピッドマイクロスフィアによる抗癌剤のリンパ系送達
遠藤 浩孝熊倉 克頼大森 裕正奥村 睦男浮ケ谷 正関 俊暢從二 和彦
著者情報
ジャーナル フリー

2000 年 15 巻 5 号 p. 457-465

詳細
抄録

Lipid microspheres (LM) containing lipophilic prodrug of 5'-deoxy-5-fluorouridine(5'-DFUR), 2', 3'-didecanoyl-5'-deoxy-5-fluorouridine(C 10-5'-DFUR), were prepared. The median diameter of LM containing C 10-5'-DFUR(C 10-5'-DFUR-LM) was about 200 nm, which was unchanged during storage for 1 week at 5°C. We analyzed plasma concentration and cumulative lymphatic transport of drug following oral administration of C 10-5'-DFUR-L to rats, as compared with 5'-DFUR aqueous salutions(5'-DFUR-W) or 5'-DFUR added to LM (5'-DFUR+LM). Effect of simultaneous use of C 10-5'-DFUR and soybean oil or lecithin which is components of LM on lymphatic delivery of drug was also investigated. The plasma concentration of 5'-DFUR rapidly declined following administration of 5'-DFUR-W or 5'-DFUR+LM. In contrast, the plasma concentration of 5'-DFUR was sustained for 24 hr in all cases of formulations containing C 10-5'-DFUR. On the other hand, the cumulative lymphatic transport of the drug following the co-administration of C 10-5'-DFUR and soybean oil or lecithin was higher than 5'-DFUR-W and 5'-DFUR+LM. Especially, in the case of C 10-5'-DFUR-LM, the cumulative lymphatic transport was higher than any other formulation. Those results indicate that administration of lipophilic drug incorporated in LM is effective for directed delivery of the drug to lymph duct, due partly to direct transmucosal passage of the intact LM containing the drug.

著者関連情報
© 日本DDS学会
前の記事
feedback
Top